A Dendritic Cell Cancer Vaccine of Matured Phenotype Downregulates Peripheral Regulatory T Cell Frequency and Identification of Plasma Protein Profiles Predicting Vaccine Efficacy - Results from a Phase II Study

被引：0
|
作者：
Wang, Who-Whong [1 ]
Chia, John [1 ]
Tan, Sze Huey [1 ]
Zocca, Mai-Britt [2 ]
Claesson, Mogens H. [3 ]
Toh, Han Chong [1 ]
机构：
[1] Natl Canc Ctr, Singapore, Singapore
[2] Dandrit Biotech A S, Copenhagen, Denmark
[3] Univ Copenhagen, Copenhagen, Denmark
来源：
MOLECULAR THERAPY | 2009年 / 17卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：S208 / S208
页数：1
相关论文
共 50 条
  • [21] Attenuating regulatory T cell induction by TLR agonists through inhibition of p38 MAPK signaling in dendritic cells enhances their efficacy as vaccine adjuvants and cancer immunotherapeutics
    Jarnicki, Andrew G.
    Conroy, Helen
    Brereton, Corinna
    Donnelly, Graham
    Toomey, Deirdre
    Walsh, Kevin
    Sweeney, Cheryl
    Leavy, Olive
    Fletcher, Jean
    Lavelle, Ed C.
    Dunne, Padraic
    Milis, Kingston H. G.
    JOURNAL OF IMMUNOLOGY, 2008, 180 (06): : 3797 - 3806
  • [22] Phase I/II Clinical Trial of CpG-Activated Whole Cell Vaccine in Mantle Cell Lymphoma (MCL): Results in Safety and Efficacy from Planned Interim Analysis
    Chu, Michael P.
    Brody, Joshua
    Kohrt, Holbrook E.
    Frank, Matthew J.
    Khodadoust, Michael
    Reddy, Sunil
    Advani, Ranjana H.
    Gupta, Neel K.
    Laport, Ginna
    Maeda, Lauren S.
    Meyer, Everett
    Miklos, David B.
    Negrin, Robert
    Rezvani, Andrew R.
    Weng, Wen-Kai
    Sheehan, Kevin
    Faham, Malek
    Czerwinski, Debra K.
    Okada, Ami
    Levy, Ronald
    BLOOD, 2015, 126 (23)
  • [23] A phase II study evaluating the safety and efficacy of an adenovirus-DLMP1-LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma
    Chia, W. K.
    Wang, W. -W.
    Teo, M.
    Tai, W. M.
    Lim, W. T.
    Tan, E. H.
    Leong, S. S.
    Sun, L.
    Chen, J. J.
    Gottschalk, S.
    Toh, H. C.
    ANNALS OF ONCOLOGY, 2012, 23 (04) : 997 - U8
  • [24] Allogeneic partially HLA-matched dendritic cells (DC) as a vaccine in metastatic renal cell cancer (mRCC): Final analysis of a clinical phase I/II study
    Floercken, Anne
    Kopp, Joachim
    Movassaghi, Kamran
    van Lessen, Antje
    Takvorian, Anna
    Schoenemann, Constanze
    Joehrens, Korinna
    Moebs, Markus
    Sawitzki, Birgit
    Doerken, Bernd
    Pezzutto, Antonio
    Westermann, Joerg
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [25] PRELIMINARY RESULTS FROM AN OPEN-LABEL, PHASE II STUDY OF TIPIFARNIB IN RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA
    Witzig, T.
    Sokol, L.
    Jacobsen, E.
    Advani, R.
    Mondejar, R.
    Piris, M.
    Burrows, F.
    Melvin, C.
    Mishra, V.
    Scholz, C.
    Gualberto, A.
    HAEMATOLOGICA, 2017, 102 : 222 - 222
  • [26] Efficacy and safety of cancer vaccine with 4-fold gene-modified allogeneic tumor cells: Results of the phase I/II ASET study in patients with advanced renal cell carcinoma
    Weikert, Steffen
    Gruenwald, Viktor
    Schmidt-Wolf, Ingo G. H.
    Hauser, Stefan
    Kapp, Kerstin
    Schmidt, Manuel
    Schroff, Matthias
    Weith, Ekaterina
    Tschaika, Marina
    Wittig, Burghardt
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [27] Efficacy and Safety of Axitinib in Patients With Advanced Non-Small-Cell Lung Cancer: Results From a Phase II Study
    Schiller, Joan H.
    Larson, Timothy
    Ou, S-H. Ignatius
    Limentani, Steven
    Sandler, Alan
    Vokes, Everett
    Kim, Sinil
    Liau, Katherine
    Bycott, Paul
    Olszanski, Anthony J.
    von Pawel, Joachim
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (23) : 3836 - 3841
  • [28] Quality of T-cell responses versus reduction in viral load: results from an exploratory phase II clinical study of Vacc-4x, a therapeutic HIV vaccine
    Ellefsen-Lavoie, K.
    Rockstroh, J.
    Pollard, R.
    Pantaleo, G.
    Podzamczer, D.
    Asmuth, D.
    van Lunzen, J.
    Arasteh, K.
    Schuemann, D.
    Peters, B.
    Clotet, B.
    Hardy, D.
    Lazzarin, A.
    Gatell, J.
    Sommerfelt, M. A.
    Baksaas, I.
    Wendel-Hansen, V.
    Sorensen, B.
    RETROVIROLOGY, 2012, 9
  • [29] Quality of T-cell responses versus reduction in viral load: results from an exploratory phase II clinical study of Vacc-4x, a therapeutic HIV vaccine
    K Ellefsen-Lavoie
    J Rockstroh
    R Pollard
    G Pantaleo
    D Podzamczer
    D Asmuth
    J van Lunzen
    K Arastéh
    D Schürmann
    B Peters
    B Clotet
    D Hardy
    A Lazzarin
    J Gatell
    MA Sommerfelt
    I Baksaas
    V Wendel-Hansen
    B Sørensen
    Retrovirology, 9
  • [30] Low-dose temozolomide modulation of peripheral blood regulatory T cells before dendritic cell-based vaccination in metastatic melanoma: Phase I/II study
    Ridolfi, L.
    Fiammenghi, L.
    Petrini, M.
    Granato, A.
    Ancarani, V.
    Pancisi, E.
    Guidoboni, M.
    Riccobon, A.
    Ascierto, P. A.
    Ridolfi, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345